Patent · US Active

4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

US9895442B2 · kind B2 · utility

2Cited by

13References

24Claims

0Family size

Assignee

Riboscience LLC · US

Inventors

Mark Smith · Saffron Walden, GB
Klaus G. Klumpp · West Chester, US

Key dates

Filing date	May 15, 2014
Grant date	Feb 20, 2018
Priority date	—
Expiry date	Oct 31, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/11
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to the compound of Formula I:Also disclosed are pharmaceutical compositions comprising the compound of Formula I, methods of using the compound of Formula I and/or compositions comprising the compound of Formula I for the treatment of HCV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.